Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists (Q43977400)

28 November 2017

Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists (English)

1 reference

28 November 2017

M J Millan

1

1 reference

28 November 2017

S Girardon

2

1 reference

28 November 2017

J Mullot

3

1 reference

28 November 2017

M Brocco

4

1 reference

28 November 2017

A Dekeyne

5

1 reference

28 November 2017

1 April 2002

1 reference

28 November 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Neuropharmacology

1 reference

28 November 2017

42

1 reference

28 November 2017

5

1 reference

28 November 2017

677-684

1 reference

Effect of 5-[3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy]-1,3-benzodioxole HCl (MKC-242), a novel 5-HT1A-receptor agonist, on aggressive behavior and marble burying behavior in mice.

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Inhibition of shock-induced foot tapping behaviour in the gerbil by a tachykinin NK1 receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Non-peptide antagonists, CP-96,345 and RP 67580, distinguish species variants in tachykinin NK1 receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Reversal of behavioural and electrophysiological correlates of experimental peripheral neuropathy by the NK1 receptor antagonist GR205171 in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

The pharmacology of impulsive behaviour in rats V: the effects of drugs on responding under a discrimination task using unreliable visual stimuli.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

NKP608, an NK1 receptor antagonist, has an anxiolytic action in the social interaction test in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Pharmacological properties of a potent and selective nonpeptide substance P antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Toward a neurobiology of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Effect of neurokinin-I receptor antagonists on the function of 5-HT and noradrenaline neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Sustained blockade of neurokinin-1 receptors enhances serotonin neurotransmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Tachykinin NK1 receptor antagonists enhance stress-induced c-fos in rat locus coeruleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Multicenter double-blind comparison of sertraline and desipramine for concurrent obsessive-compulsive and major depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Substance P receptor (NK-1) in the central nervous system: possible functions from a morphological aspect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Distinct mechanism for antidepressant activity by blockade of central substance P receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

The selective neurokinin (NK)(1) antagonist, GR205,171, stereospecifically enhances mesocortical dopaminergic transmission in the rat: a combined dialysis and electrophysiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

GR205171 blocks apomorphine and amphetamine-induced conditioned taste aversions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Nonpeptide antagonists of the NK1 tachykinin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

The induction of pain: an integrative review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Selective blockade of neurokinin (NK)(1) receptors facilitates the activity of adrenergic pathways projecting to frontal cortex and dorsal hippocampus in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Multicentre, double-blind, comparison of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Effects of 5-HT uptake inhibitors, agonists and antagonists on the burying of harmless objects by mice; a putative test for anxiolytic agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Neurotransmitter functions of mammalian tachykinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

The NK1-receptor antagonist NKP608 has an antidepressant-like effect in the chronic mild stress model of depression in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Possible role(s) of neurokinins in CNS development and neurodegenerative or other disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Neuroanatomical localisation of Substance P in the CNS and sensory neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive--compulsive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Antinociceptive profiles of non-peptidergic neurokinin1 and neurokinin2 receptor antagonists: a comparison to other classes of antinociceptive agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

The substance P antagonist L-760,735 inhibits stress-induced NK(1) receptor internalisation in the basolateral amygdala

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Selective serotonin re-uptake inhibitors decrease schedule-induced polydipsia in rats: a potential model for obsessive compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

Obsessive-compulsive disorder: psychobiological approaches to diagnosis, treatment, and pathophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0028-3908%2802%2900021-7

10.1016/S0028-3908(02)00021-7

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference